Cynata Therapeutics Statistics
Total Valuation
CYYNF has a market cap or net worth of 67.74 million. The enterprise value is 64.15 million.
| Market Cap | 67.74M |
| Enterprise Value | 64.15M |
Important Dates
The next estimated earnings date is Friday, February 20, 2026.
| Earnings Date | Feb 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 241.75M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +14.10% |
| Shares Change (QoQ) | +22.37% |
| Owned by Insiders (%) | 8.35% |
| Owned by Institutions (%) | 13.43% |
| Float | 187.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 54.81 |
| PB Ratio | 17.27 |
| P/TBV Ratio | 17.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.42 |
| EV / Sales | 47.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.40
| Current Ratio | 4.40 |
| Quick Ratio | 4.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -142.29% and return on invested capital (ROIC) is -91.02%.
| Return on Equity (ROE) | -142.29% |
| Return on Assets (ROA) | -77.08% |
| Return on Invested Capital (ROIC) | -91.02% |
| Return on Capital Employed (ROCE) | -160.67% |
| Weighted Average Cost of Capital (WACC) | 9.72% |
| Revenue Per Employee | 617,957 |
| Profits Per Employee | -3.08M |
| Employee Count | 2 |
| Asset Turnover | 0.24 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +59.42% in the last 52 weeks. The beta is 1.00, so CYYNF's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | +59.42% |
| 50-Day Moving Average | 0.37 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 49.19 |
| Average Volume (20 Days) | 3,264 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CYYNF had revenue of 1.24 million and -6.16 million in losses. Loss per share was -0.03.
| Revenue | 1.24M |
| Gross Profit | 1.24M |
| Operating Income | -6.30M |
| Pretax Income | -6.16M |
| Net Income | -6.16M |
| EBITDA | -6.12M |
| EBIT | -6.30M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 3.31 million in cash and n/a in debt, with a net cash position of 3.31 million.
| Cash & Cash Equivalents | 3.31M |
| Total Debt | n/a |
| Net Cash | 3.31M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.92M |
| Book Value Per Share | 0.02 |
| Working Capital | 2.71M |
Cash Flow
| Operating Cash Flow | -5.72M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -509.82% |
| Pretax Margin | -498.14% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CYYNF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.10% |
| Shareholder Yield | -14.10% |
| Earnings Yield | -9.09% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CYYNF has an Altman Z-Score of 0.28 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.28 |
| Piotroski F-Score | 2 |